HDFCCC Newsletter
logo
VIEW AS A WEB PAGE  
line
JANUARY ANNOUNCEMENTS
feature
 
 
The HDFCCC Community Advisory Board: Champions for Health Equity
Over the past 15 years, the cancer center's Community Advisory Board (CAB) has become one of UCSF's most instrumental community outreach groups for improving health equity. Here CAB Chair Arnold Perkins and Dr. Kim Rhoads discuss why CABs are critical to the work of NCI cancer centers and the communities they serve. [read more]
news Cancer Metastasis is Target of New Research Initiative
Six UCSF researchers have won an Endeavor Award to build a new research collaborative at the University focused on decoding the "rulebook" of metastatic cancer as a pathway to new treatments.
news Precision Medicine World Conference (PMWC) 2021 to Focus on COVID-19
Several UCSF scientists and clinicians will present their work confronting the coronavirus pandemic at PMWC 2021. The three-day virtual forum takes place Jan 25-27 and offers free registration.
 
resource
 
  On Jan 29, the UCSF Center for Tobacco Control Research and Education (CTCRE) will host its annual "It's About a Billion Lives" Tobacco Research Symposium.

The program features a keynote presentation by Stanton Glantz, PhD, and closing remarks by Alan Ashworth, PhD, FRS.

> view details
> register

 
 
Awards & Distinctions
Alexander Marson, MD, PhD and team received a grant of $11M over 5 years from the National Institute of Allergy and Infectious Diseases for a project entitled, "Inherited T cell defects: Diagnosis, mechanisms and treatments."
Sunny Wang, MD and James Brown, MD received a grant of $4.5 million over 5 years from the VA Office of Research and Development for a project entitled, "Lung precision oncology program."
Alan Baik, MD; Vanessa Kennedy, MD; Amanda Marinoff, MD; Christopher Molina, MD; and Jacob Young, MD were selected as fellows for the Chan Zuckerberg Biohub Physician-Scientist Fellowship Program.
Eric Collisson, MD; Jay Debnath, MD, PhD; Andrei Goga, MD, PhD; Sarah Knox, PhD; Jeroen Roose, PhD; and Valerie Weaver, PhD received an Endeavor Award from the Mark Foundation for Cancer Research. Read more.
In the News
 
news [VIDEO] NOVA Series: Secrets In Our DNA
PBS | Jan 13, 2021
news The Exploration of PSMA PET as a Possible Theranostic Agent in Thyroid Cancer
UCSF Radiology | Jan 11, 2021
news 'Invisible' Stem Cells Evade Natural Killer Cells Using Immune 'Off-Switch'
UCSF | Jan 8, 2021
 
news What the SF Bay Area Can Teach Us About Fighting a Pandemic
The New Yorker | Jan 4, 2021
news E-Cigarettes, as Consumer Products, Do Not Help People Quit Smoking, Study Finds
UCSF | Dec 22, 2020
news Autobahn Collaboration to Accelerate UCSF Innovation from Bench to Bedside
UCSF Innovation | Dec 18, 2020
 
 
 
Recent Publications

Cooperberg MR, Cowan JE, Lindquist KJ, Kobayashi Y, Simko JP, Bengtsson H, Singh K, Ngo V, Avila A, Newcomb LF, Tretriakova M, Lin DW, Stone S, Carroll PR, Paris PL. Multiple Tissue Biomarkers Independently and Additively Predict Prostate Cancer Pathology Outcomes. Eur Urol. 2021 Jan;79(1):141-149.

Ma L, Gonzalez-Junca A, Zheng Y, Ouyang H, Illa-Bochaca I, Horst KC, Krings G, Wang Y, Fernandez-Garcia I, Chou W, Barcellos-Hoff MH. Inflammation mediates the development of aggressive breast cancer following radiotherapy. Clin Cancer Res. 2021 Jan 5:clincanres.3215.2020.

Humtsoe JO, Kim HS, Leonard B, Ling S, Keam B, Marchionni L, Afsari B, Considine M, Favorov AV, Fertig EJ, Kang H, Ha PK. Newly identified members of fibroblast growth factor receptor 1 splice variants engage in crosstalk with the AXL/AKT axis in salivary adenoid cystic carcinoma. Cancer Res. 2021 Jan 6:canres.1780.2020.

Naidus E, Bouquet J, Oh DY, Looney TJ, Yang H, Fong L, Standifer NE, Zhang L. Early changes in the circulating T cells are associated with clinical outcomes after PD-L1 blockade by durvalumab in advanced NSCLC patients. Cancer Immunol Immunother. 2021 Jan 9.

Education and Training

trainingRemembering Community Health in Research: Using Basic Science to Solve Complex Health Problems
A two-part series offered by the HDFCCC Office of Education and Training. You must attend Part 1 to compete for funding in Part 2.

Part 1 | March 31, 12:00 pm - 1:30 pm
Panel of basic & translational scientists who use collaborations with other scientific disciplines & communities to improve their science & accelerate its impact on population health. Register.
Part 2 | Date TBD - Pilot Award Competition
Trainees present community focused research ideas to a team of community members. Two awards of up to $15,000 will be awarded.
Events
Jan 15: Friday Cancer Center Seminar Series
Julien Marie, PhD, will present, "Cooperation between Cancer Cells and Regulatory T Cells to Promote Immune-escape."
Jan 21: UC Pancreatic Cancer Consortium Seminar Series
Rebekah White, MD, FACS, will present, "Irreversible Electroporation: Generating Systemic Immune Responses with Local Therapy."
Jan 27-Feb 17: 1st Annual UCSF Health Services Research Symposium
A series of four webinars on the topic, "Accelerating our Impact on Health: Methods, Strategies, and Opportunities."
Feb 10: Cancer Center Grand Rounds Series
Featuring presentations by Drs. Steve Braunstein, Nancy Ann Oberheim Bush, and Raj Pruthi.
  UNSUBSCRIBE | ABOUT | CONTACT facebook twitter